Houlihan Lokey Advises Petauri Health

• 举报此文章

Mark Martin

Mark Martin

Managing Director at Houlihan Lokey

发布日期: 2023年6月14日

+ 关注

Houlihan Lokey is pleased to announce that Petauri Health, a purpose-built pharmaceutical services platform backed by Oak Hill Capital (Oak Hill), has acquired The Kinetix Group (TKG), a strategic advisory, access marketing, and medical affairs agency.

For more information, click here: https://hl.com/about-us/transactions/transaction-detail/68719478604/

要查看或添加评论，请登录

Mark Martin的更多文章

• Strong Momentum in Pharma Commercialization

  2024年12月4日

  Strong Momentum in Pharma Commercialization

  Houlihan Lokey is pleased to share its featured 2024 transactions in pharma commercialization, making it one of the…

  113

  3 条评论
• Houlihan Lokey Advises Periscope Equity

  2024年11月15日

  Houlihan Lokey Advises Periscope Equity

  Houlihan Lokey is pleased to announce that Periscope Equity, a Chicago-based private equity firm that partners with…

  99
• Houlihan Lokey Advises Minds + Assembly

  2024年11月14日

  Houlihan Lokey Advises Minds + Assembly

  Houlihan Lokey is pleased to announce that MINDS + ASSEMBLY, a portfolio company of Amulet Capital Partners, LP, has…

  133

  4 条评论
• THL Partners acquires Red Nucleus

  2024年10月24日

  THL Partners acquires Red Nucleus

  Houlihan Lokey is pleased to announce that Red Nucleus, a leading provider of strategic life science solutions, has…

  218

  7 条评论
• Houlihan Lokey Advises Petauri

  2024年6月18日

  Houlihan Lokey Advises Petauri

  Houlihan Lokey is pleased to announce that Petauri , a leading purpose-built pharmaceutical services platform backed by…

  114

  3 条评论
• Pharma Commercialization Thought Leader Interview Series— Doug Fulling, Precision AQ

  2024年6月1日

  Pharma Commercialization Thought Leader Interview Series— Doug Fulling, Precision AQ

  We are pleased to present the Thought Leader Interview Series—a collection of one-on-ones presented by the Houlihan…

  97

  4 条评论
• Pharma Commercialization Market Update| December 2023

  2023年12月20日

  Pharma Commercialization Market Update| December 2023

  Houlihan Lokey is pleased to present its Pharma Commercialization Market Update for December 2023. We have included…

  68

  1 条评论
• Thought Leader Interview Series—Lucid Group

  2023年10月24日

  Thought Leader Interview Series—Lucid Group

  Excited to share my interview with Dennis O'Brien and Rick S. of Lucid Group Group.

  61
• Pharma Commercialization: A Deep Dive in Market Access

  2023年8月7日

  Pharma Commercialization: A Deep Dive in Market Access

  The increasing complexity of novel therapeutics has created a tailwind for pharmaceutical research and development…

  92

  2 条评论
• Thought Leader Interview Series—Rob Barker, CEO, OPEN Health

  2023年7月18日

  Thought Leader Interview Series—Rob Barker, CEO, OPEN Health

  Houlihan Lokey is pleased to present the July edition of the Thought Leader Interview Series—a collection of…

  78

Show more

See all articles